PR Newswire

BiomEdit's First-of-its-Kind Engineered Bacterial Biologic for Poultry Receives Conditional Licensure from USDA

BiomEdit, a pioneering animal health biotechnology company, today announced that the U.S. Department of Agriculture's Center ...
newswire

Jaguar Health Completes Final Regulatory Filing for Conditional New Animal Drug Approval of Canalevia (Crofelemer) to Treat Exercise-induced Diarrhea (EID) in Dogs

, May 3, 2022 (Newswire.com) - Canalevia® Would Be the First and Only Treatment for EID in Dogs To Receive Any Type of Approval From FDA Jaguar Health, Inc. (NASDAQ:JAGX), under its Jaguar Animal ...
newswire

Jaguar Health Completes Final Major Regulatory Filing for Conditional New Animal Drug Approval of Canalevia (Crofelemer) to Treat Exercise-induced Diarrhea in Dogs

, February 10, 2022 (Newswire.com) - Canalevia ™ would be first and only FDA-approved plant-based medicine for working dogs that suffer from diarrhea Jaguar Health, Inc. (NASDAQ:JAGX), under its ...
Nasdaq

Jaguar Health Completes Filing of New Animal Drug Application for Conditional Approval of Canalevia-CA1 (Crofelemer) to Treat Chemotherapy-Induced Diarrhea in Dogs, Clearing ...

Canalevia™-CA1 is the first and only oral plant-based prescription drug candidate for CID in dogsJaguar kicks off educational awareness contest in honor of International Jaguar Day; Click here to ...